Zacks Investment Research upgraded shares of AMYRIS INC (AMRS) from NEUTRAL to OUTPERFORM on January 08, 2013, with a target price of $4.00.
Amyris INC is an integrated renewable products company applying industrial synthetic biology to genetically modify microorganisms to serve as living factories. Amyris designs these microorganisms to produce defined molecules for use as renewable chemicals and transportation fuels. The Company is engaged in the development of farmesene- a molecule, which serves as the base chemical building block for a wide range of renewable products to replace existing products that are derived from petroleum, plant or animal sources and that may be of lower quality or higher price. Amyris INC is headquartered in Emeryville, CA.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on AMYRIS INC (AMRS),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment